Cisplatin, which increased CD24 expression, is suggested to induce stem-to-progenitor differentiation in tpMDA and tsMDA, and this cisplatin-triggered cell differentiation was previously reported in breast cancer [49]. The gene discussed is CD24; the disease is breast cancer.